Xp Inc (XPBR31)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 84.62 |
|---|---|
| 52-week range | 76.22 – 161.74 |
| Return, 1 month / 3 months | −20.2% / −0.4% |
| Return, 1 year / 3 years | −8.5% / −6.8% |
| Trend | Below its 200-day average |
| RSI (14) | 30 |
| Volatility (1 year) | 75.6% |
| Worst drawdown (1 year) | -47.1% |
| Average daily value traded | 148.70M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
XP Inc is a Brazilian financial services company that provides investment brokerage and advisory services to individual investors and other clients. Through its platform, it offers access to a range of investment products, including funds, fixed income securities and equities, along with financial education and wealth management support. The company is based in Brazil and serves retail investors, independent financial advisors and institutional clients across the country.
On this site Xp Inc appears as a stock on the B3 Stock Exchange (Brazil), code XPBR31, with prices in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Xp Inc (XPBR31) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 84.62 on 27 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 938 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.5% and over the last three months it fell 0.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.2% | ||
| From 52-week high | -47.1% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -0.4% | ||
| 6-month return | -12.0% | ||
| 12-month return, skipping the last month | 14.7% | ||
| Stability (higher is calmer) | 16 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 75.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -47.1% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 148.70M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −46.7% |
|---|---|
| 1 month | −20.2% |
| 3 months | −0.4% |
| 6 months | −12.0% |
| 1 year | −8.5% |
| 3 years | −6.8% |
| 5 years | −48.4% |
Signals
| 50-day / 200-day average | 113.17 / 97.53 |
|---|---|
| Golden / death cross (60 days) | Golden, 18 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.28 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jun 2026 | KYD 1.0203 |
| 9 Dec 2025 | KYD 0.9904 |
| 9 Dec 2024 | KYD 4.0607 |
| 11 Dec 2023 | KYD 3.5271 |
| 8 Sep 2023 | KYD 2.8847 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.